American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evidence-Based Minireview: Full dose, modified dose, or no anticoagulation for patients with cancer and acute VTE and thrombocytopenia
    Review

    Patell, R.; Zwicker, J. I.
    Hematology-American Society of Hematology Education Program (2022)

    Fulltext@MSK | Save
  • Do all patients with primary refractory/first relapse of HL need autologous stem cell transplant?
    Review

    Moskowitz, A. J.
    Hematology-American Society of Hematology Education Program (2022)

    Fulltext@MSK | Save
  • Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation
    Journal Article

    Nawas, M. T.; Sanchez-Escamilla, M.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Sauter, C. S.; Giralt, S. A.; Perales, M. A.; Scordo, M.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy
    Journal Article

    Handa, S.; Lee, J. O.; Derkach, A.; Stone, R. M.; Saven, A.; Altman, J. K.; Grever, M. R.; Rai, K. R.; Shukla, M.; Vemuri, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • The international consensus classification of mature lymphoid neoplasms: A report from the Clinical Advisory Committee
    Guidelines

    Campo, E.; Jaffe, E. S.; Cook, J. R.; Quintanilla-Martinez, L.; Swerdlow, S. H.; Anderson, K. C.; Brousset, P.; Cerroni, L.; de Leval, L.; Dirnhofer, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • International consensus classification of myeloid neoplasms and acute leukemias: Integrating morphologic, clinical, and genomic data
    Journal Article

    Arber, D. A.; Orazi, A.; Hasserjian, R. P.; Borowitz, M. J.; Calvo, K. R.; Kvasnicka, H. M.; Wang, S. A.; Bagg, A.; Barbui, T.; Branford, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Genomic profiling for clinical decision making in lymphoid neoplasms
    Journal Article

    de Leval, L.; Alizadeh, A. A.; Bergsagel, P. L.; Campo, E.; Davies, A.; Dogan, A.; Fitzgibbon, J.; Horwitz, S. M.; Melnick, A. M.; Morice, W. G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Role of stem cell transplant in CD30(+) PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2
    Journal Article

    Savage, K. J.; Horwitz, S. M.; Advani, R.; Christensen, J. H.; Domingo-Domenech, E.; Rossi, G.; Morschhauser, F.; Alpdogan, O.; Suh, C.; Tobinai, K.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma
    Journal Article

    Younes, A.; Burke, J. M.; Diefenbach, C.; Ferrari, S.; Khan, C.; Sharman, J. P.; Tani, M.; Ujjani, C.; Vitolo, U.; Yuen, S.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Primary central nervous system lymphoma
    Review

    Schaff, L. R.; Grommes, C.
    Blood (2022)

    Fulltext@MSK | Save